360
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Levels of F2-isoprostanes, F4-neuroprostanes, and total nitrate/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury

, , , , ORCID Icon &
Pages 1419-1430 | Received 21 Apr 2015, Accepted 02 Aug 2015, Published online: 28 Aug 2015

References

  • Montuschi P, Barnes P, Roberts LJ. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703–717.
  • Roberts LJ, Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 2004;128:173–186.
  • Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505–513.
  • Belik J, Gonzalez-Luis GE, Perez-Vizcaino F, Villamor E. Isoprostanes in fetal and neonatal health and disease. Free Radic Biol Med 2010;48:177–188.
  • Morrow JD. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 2006;12:895–902.
  • Liu W, Morrow JD, Yin H. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009;47:1101–1107.
  • Milne GL, Gao B, Terry ES, Zackert WE, Sanchez SC. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic Biol Med 2013;59:36–44.
  • Lin CL, Hsu YT, Lin TK, Morrow JD, Hsu JC, Hsu YH, et al. Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2006;40:1466–1473.
  • Hsieh YP, Lin CL, Shiue AL, Yin H, Morrow JD, Hsu JC, et al. Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2009;47:814–824.
  • Chang EF, Claus CP, Vreman HJ, Wong RJ, Noble-Haeusslein LJ. Heme regulation in traumatic brain injury: relevance to the adult and developing brain. J Cereb Blood Flow Metab 2005;25:1401–1417.
  • Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99:4–9.
  • Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 2008;7:728–741.
  • Cornelius C, Crupi R, Calabrese V, Graziano A, Milone P, Pennisi G, et al. Traumatic brain injury: oxidative stress and neuroprotection. Antioxid Redox Signal 2013;19:836–853.
  • Robertson CL. Mitochondrial dysfunction contributes to cell death following traumatic brain injury in adult and immature animals. J Bioenerg Biomembr 2004;36:363–368.
  • Weber JT. Altered calcium signaling following traumatic brain injury. Front Pharmacol 2012;3:60.
  • Nayak C, Nayak D, Raja A, Rao A. Relationship between markers of lipid peroxidation, thiol oxidation and Glasgow coma scale scores of moderate head injury patients in the 7 day post-traumatic period. Neurol Res 2008;30:461–464.
  • Nayak C, Nayak D, Bhat S, Raja A, Rao A. Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients. Clin Chem Lab Med 2007;45:629–633.
  • Kasprzak HA, Wozniak A, Drewa G, Wozniak B. Enhanced lipid peroxidation processes in patients after brain contusion. J Neurotrauma 2001;18:793–797.
  • Paolin A, Nardin L, Gaetani P, Rodriguez YB, Pansarasa O, Marzatico F. Oxidative damage after severe head injury and its relationship to neurological outcome. Neurosurgery 2002; 51:949–954.
  • Bayir H, Kagan VE, Tyurina YY, Tyurin V, Ruppel RA, Adelson PD, et al. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res 2002;51:571–578.
  • Varma S, Janesko KL, Wisniewski SR, Bayir H, Adelson PD, Thomas NJ, Kochanek PM. F2-isoprostane and neuron- specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. J Neurotrauma 2003; 20:781–786.
  • Bayir H, Marion DW, Puccio AM, Wisniewski SR, Janesko KL, Clark RS, Kochanek PM. Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma 2004;21:1–8.
  • Seifman MA, Adamides AA, Nguyen PN, Vallance SA, Cooper DJ, Kossmann T, et al. Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray. J Cereb Blood Flow Metab 2008;28: 684–696.
  • Chen TW, Lin CL, Yen HC. Elevation of F2-isoprostanes and F4-neuroprostanes levels in cerebrospinal fluid of patients with traumatic brain injury (Abstract). Free Radic Biol Med 2009;47:S108.
  • Corcoran TB, Mas E, Barden AE, Durand T, Galano JM, Roberts LJ, et al. Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxid Redox Signal 2011;15:2663–2667.
  • Cherian L, Hlatky R, Robertson CS. Nitric oxide in traumatic brain injury. Brain Pathol 2004;14:195–201.
  • O’Connell KM, Littleton-Kearney MT. The role of free radicals in traumatic brain injury. Biol Res Nurs 2013;15:253–263.
  • Uzan M, Tanriover N, Bozkus H, Gumustas K, Guzel O, Kuday C. Nitric oxide (NO) metabolism in the cerebrospinal fluid of patients with severe head injury. Inflammation as a possible cause of elevated no metabolites. Surg Neurol 2001;56:350–356.
  • Urwin SC, Menon DK. Comparative tolerability of sedative agents in head-injured adults. Drug Saf 2004;27:107–133.
  • Roberts DJ, Haroon B, Hall RI. Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm. Drugs 2012;72:1881–1916.
  • Silvers KM, Sluis KB, Darlow BA, McGill F, Stocker R, Winterbourn CC. Limiting light-induced lipid peroxidation and vitamin loss in infant parenteral nutrition by adding multivitamin preparations to Intralipid. Acta Paediatr 2001; 90:242–249.
  • Mouithys-Mickalad A, Hans P, by-Dupont G, Hoebeke M, Deby C, Lamy M. Propofol reacts with peroxynitrite to form a phenoxyl radical: demonstration by electron spin resonance. Biochem Biophys Res Commun 1998;249:833–837.
  • Kohnen SL, Mouithys-Mickalad AA, by-Dupont GP, Deby CM, Hans P, Lamy ML, Noels AF. Investigation of the reaction of peroxynitrite with propofol at acid pH: predominant production of oxidized, nitrated, and halogenated derivatives. Nitric Oxide 2003;8:170–181.
  • Liu YC, Chang AY, Tsai YC, Chan JY. Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia. J Biomed Sci 2009;16:8.
  • Ma L, Wu XY, Zhang LH, Chen WM, Uchiyama A, Mashimo T, Fujino Y. Propofol exerts anti-inflammatory effects in rats with lipopolysaccharide-induced acute lung injury by inhibition of CD14 and TLR4 expression. Braz J Med Biol Res 2013;46:299–305.
  • Peng M, Ye JS, Wang YL, Chen C, Wang CY. Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia. Inflamm Res 2014;63:411–418.
  • Vasileiou I, Xanthos T, Koudouna E, Perrea D, Klonaris C, Katsargyris A, Papadimitriou L. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol 2009;605:1–8.
  • Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004;10:3639–3649.
  • Ozturk E, Demirbilek S, Koroglu A, But A, Begec ZO, Gulec M, et al. Propofol and erythropoietin antioxidant properties in rat brain injured tissue. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:81–86.
  • Basu S, Mutschler DK, Larsson AO, Kiiski R, Nordgren A, Eriksson MB. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001;50:341–348.
  • Basu S, Miclescu A, Sharma H, Wiklund L. Propofol mitigates systemic oxidative injury during experimental cardiopulmonary cerebral resuscitation. Prostaglandins Leukot Essent Fatty Acids 2011;84:123–130.
  • Krogh-Madsen R, Plomgaard P, Akerstrom T, Moller K, Schmitz O, Pedersen BK. Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2008;294:E371–E379.
  • Helbock HJ, Motchnik PA, Ames BN. Toxic hydroperoxides in intravenous lipid emulsions used in preterm infants. Pediatrics 1993;91:83–87.
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–84.
  • Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480–484.
  • Milne GL, Yin H, Brooks JD, Sanchez S, Jackson RL, Morrow JD. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 2007;433:113–126.
  • Yen HC, Wei HJ, Chen TW. Analytical variables affecting analysis of F2-isoprostanes and F4-neuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry. Biomed Res Int 2013;2013:810915.
  • Yen HC, Wei HJ, Lin CL. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry. Free Radic Res 2015;49:861–880.
  • Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998;273:13605–13612.
  • Arneson KO, Roberts LJ. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Methods Enzymol 2007;433:127–143.
  • Ballester M, Llorens J, Garcia-de-la-Asuncion J, Perez-Griera J, Tebar E, Martinez-Leon J, et al. Myocardial oxidative stress protection by sevoflurane vs. propofol: a randomised controlled study in patients undergoing off-pump coronary artery bypass graft surgery. Eur J Anaesthesiol 2011;28: 874–881.
  • Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, et al. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 2006;281:4616–4623.
  • Florian JP, Pawelczyk JA. Sympathetic and haemodynamic responses to lipids in healthy human ageing. Exp Physiol 2010;95:486–497.
  • Florian JP, Pawelczyk JA. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci (Lond) 2010;118:61–69.
  • Prasertsom W, Phillipos EZ, Van Aerde JE, Robertson M. Pulmonary vascular resistance during lipid infusion in neonates. Arch Dis Child Fetal Neonatal Ed 1996;74:F95–F98.
  • Kessler U, Zachariou Z, Raz D, Poeschl J, Linderkamp O. Effects of Intralipid infusion on hemorheology and peripheral resistance in neonates and children. Pediatr Surg Int 2005; 21:197–202.
  • Shiva S. Nitrite: A physiological store of nitric oxide and modulator of mitochondrial function. Redox Biol 2013;1:40–44.
  • Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424.
  • Kirsch M, Korth HG, Wensing A, Sustmann R, de GH. Product formation and kinetic simulations in the pH range 1–14 account for a free-radical mechanism of peroxynitrite decomposition. Arch Biochem Biophys 2003;418:133–150.
  • Tisdall MM, Rejdak K, Kitchen ND, Smith M, Petzold A. The prognostic value of brain extracellular fluid nitric oxide metabolites after traumatic brain injury. Neurocrit Care 2013; 19:65–68.
  • Kandasamy R, Kanti PH, Swamy M, Abdullah J. Cerebrospinal fluid nitric oxide metabolite levels as a biomarker in severe traumatic brain injury. Int J Neurosci 2013; 123:385–391.
  • Hlatky R, Goodman JC, Valadka AB, Robertson CS. Role of nitric oxide in cerebral blood flow abnormalities after traumatic brain injury. J Cereb Blood Flow Metab 2003;23: 582–588.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.